I am an investigator, quantitative psychologist and statistician with over 20 years of experience in the field of behavioral health research. I am currently a member of the faculty in the Department of Population Health of the New York University Grossman School of Medicine and Director of the Transdisciplinary Research Methods Core of the Center for Drug Use and HIV Research (CDUHR), a NIDA-funded P30 center focused on understanding risks for HIV and other infectious diseases. I have worked on more than 30 research projects with 17 different principal investigators, most funded by the National Institutes of Health. I am usually a key member of the grant-writing team and make critical contributions on research design and analysis plans. I have applied a variety of advanced analysis approaches to complex longitudinal data including multiple imputation for missing data, structural equation modeling, generalized estimating equations, and linear and generalized linear mixed models. I taught a two-semester sequence of statistics to graduate students in psychology at the New School for Social Research for four years. I have given many invited presentations, trainings, and guest lectures. I have also given statistical and other methods support to many principal investigators, doctoral students, pre- and post-doctoral fellows, junior faculty, and research scientists.
| Dates | Name | Position while mentored | Role | Current Position |
|---|---|---|---|---|
| 2001-04 | Rebecca Sugerman | Doctoral Student, New School for Social Research | Committee Member | Pediatric Clinical Psychologist, NY Health + Hospitals |
| 2002-04 | Tatyana Biyanova | Doctoral Student, New School for Social Research | Committee Member | Research Scientist, New York State Psychiatric Institute |
| 2003-06 | Shannon Stepan | Doctoral Student, New School for Social Research | Committee Member | Clinical Psychologist, NYC |
| 2007- | Barbara Tempalski | New Investigator, NDRI | Grant proposal preparation, manuscript writing | Research Scientist, NJCRI |
| 2008- | Maria Khan | Postdoctoral Fellow, NDRI | Grant proposal preparation, manuscript writing | Associate Professor, NYU Grossman School of Medicine |
| 2010- | Ian Aronson | New Investigator, National Development and Research Institutes (NDRI) | Grant proposal preparation, manuscript writing | Principal Investigator, NDRI |
| 2010-15 | Salima Walani | Doctoral Student, NYU Meyers | Committee Member, manuscript writing | Director of Global Health Programs, March of Dimes Foundation |
| 2010-16 | Marilyn Hammer | Assistant Professor, NYU Meyers | Manuscript writing | Associate Professor, Mount Sinai |
| 2011- | Caroline Dorsen | Assistant Professor, NYU Meyers | Grant proposal preparation | Ongoing |
| 2011- | Jennifer McNeely | Assistant Professor, NYUMC | Grant proposal preparation, manuscript writing | Associate Professor, NYUMC |
| 2011-12 | Stephanie Engel | Visiting Scholar, NYU Meyers | Manuscript writing | Physician, Capio St Göran |
| 2011-13 | Joanne Ryan | Doctoral Student, NYU Meyers | Committee Member | Cross-Portfolio Medical Director, Pfizer |
| 2011-14 | Tania Williams | Doctoral Student, NYU Meyers | Committee Member | Director of Infection Prevention, Mount Sinai |
| 2011-15 | Jill Nocella | Doctoral Student, NYU Meyers | Committee Member, manuscript writing | Assistant Professor, William Paterson University |
| 2011-16 | Sarah Nadimpalli | Doctoral Student, NYU Meyers | Committee Member, manuscript writing | Research Associate, Brown University |
| 2012- | Alexandra Kutnick | Doctoral Student, NYU | Manuscript writing | Postdoctoral Fellow, NYU Meyers |
| 2012-13 | Divane Vargas | Visiting Scholar, NYU Meyers | Manuscript writing | Associate Professor, Universidade de São Paulo |
| 2012-17 | Ranekka Dean | Doctoral Student, NYU Meyers | Committee Member | Director, NYU Winthrop Hospital |
| 2013- | Sarah Nowlin | Doctoral Student, NYU Meyers | Committee Member, manuscript writing | Postdoctoral Fellow, NYU Meyers |
| 2013- | Joseph Palamar | Assistant Professor, NYUMC | Grant proposal preparation, manuscript writing | Associate Professor, NYUMC |
| 2014-2019 | Ann-Margaret Navarra | Assistant Professor, NYU Meyers | Manuscript writing | Assistant Professor, NYU Meyers |
| 2015-2020 | Ashly Jordan | Doctoral Student, CUNY | Committee Member | Postdoctoral Fellow, NYU Meyers |
| 2015-16 | Pritika Kumar | Postdoctoral Fellow, NYUMC | Manuscript writing | Researcher, HealthPartners Minneapolis, MN |
| 2017-2019 | Omar El Shahawy | Postdoctoral Fellow, NYUMC | Grant proposal preparation | Assistant Professor, NYU Grossman School of Medicine |
| 2017-2019 | Susan Malone | Research Scientist, NYU Meyers | Grant proposal preparation | Research Scientist, NYU Meyers |
| 2019- | Nan Jiang | Assistant Professor, NYU Grossman School of Medicine | Grant proposal preparation, manuscript writing | Ongoing |
| 2020- | Amanda Bunting | Postdoctoral Fellow, NYU Grossman School of Medicine | Grant proposal preparation | Ongoing |
| 2019- | Suzan Walters | Postdoctoral Fellow, NYU Meyers | Grant proposal preparation | Ongoing |
| 2020- | Rebecca Anthopolos | Assistant Professor, NYU Grossman School of Medicine | Mentoring Committee Member | Ongoing |
| 1 | Longitudinal associations between incarceration, substance use, sexual risk-taking, and STI among black MSM: Evaluation of cohort differences by age |
| 2 | The association between discriminatory police harassment and subsequent victimization among black men who have sex with men, an intersectional analyses |
| 3 | Stopping, starting, and sustaining HIV antiretroviral therapy: A mixed methods retrospective exploration among long-term survivors of HIV in high-risk contexts |
| 4 | Kurth, A., Lizcano, J., Cleland, C., Musyoki, H., Cherutich, P. (July 2017). Testing and Linkage to Care for Injecting Drug Users (TLC-IDU) in Kenya: A Baseline Assessment in Western Region. IAS, Paris, France. |
| 5 | Inwani, I., Buttolph, J., Agot, K., Cleland, C.M., Kiarie, J., Kinuthia, J., Kurth, A. (July 2017). PrEP Cohort Results from MP3 Youth Combination HIV Prevention Pilot Study. IAS, Paris, France. |
| 6 | Kurth, A., Lizcano, J., Cleland, C., Musyoki, H., Cherutich, P. (June 2017). TLC-IDU in Kenya: Linkage to Care data. IAPAC Conference, Miami, FL. |
| 7 | Kurth, A., Lizcano, J., Cleland, C., Musyoki, H., Cherutich, P. (June 2017). Testing and Linkage to Care for Injecting Drug Users (TLC-IDU) in Kenya: A Baseline Assessment in Western Region. IAPAC Conference, Miami, FL. |
| 8 | Buttolph, J., Inwani, I., Agot, K., Cleland, C.M., Kiarie, J., Kinuthia, J., and Kurth, A. (January 2017). Preliminary PrEP cohort results from MP3 Youth combination HIV prevention pilot study. Annual Meeting, University of Nairobi Collaborative Centre for Research &Training in HIV/AIDS/STIs, Nairobi, Kenya. |
| 9 | Kurth, A.E., Cleland, C.M., Chhun, N., Sidle, J.E., Were, E., Naanyu, V., Emonyi, W., Macharia, S.M., Sang, E., and Siika, A.M. (January 2017). Lessons learned from an oral fluid HIV self-testing study in a general adult population in Kenya. Annual Meeting, University of Nairobi Collaborative Centre for Research &Training in HIV/AIDS/STIs, Nairobi, Kenya. |
| 10 | Kurth, A., Lizcano, J., Cleland, C.M., Musyoki, H., and Cherutich, P. (January 2017). Testing and linkage to care for injecting drug users (TLC-IDU) in Kenya: A baseline assessment in Western Region. Annual Meeting, University of Nairobi Collaborative Centre for Research &Training in HIV/AIDS/STIs, Nairobi, Kenya. |
| 11 | Kurth, A., Lizcano, J., Cleland, C.M., Akiyama, M., Musyoki, H., and Cherutich, P. (January 2017). Hepatitis C Virus (HCV) among PWIDs in Kenya: An update. Annual Meeting, University of Nairobi Collaborative Centre for Research &Training in HIV/AIDS/STIs, Nairobi, Kenya. |
| 12 | Mackesy-Amiti, M. E., Strand, L., Nance, R., Chandler, R., Cunningham, W., Riley, E., & Cleland, C. (2016, August). An Example of Exposure Heterogeneity When Pooling Epidemiologic Studies for Meta-Analysis of Antiretroviral Medication Adherence. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 25, pp. 55-56). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL. |
| 13 | Leonard, N. R., Fletcher, R.R., Casarjian, B., Gwadz, M.V., Cleland, C.M., Rajan, S. & Salaam, R. (2014). Integrating emotional and behavioral skill building with mobile biosensor technology for at-risk adolescent mothers. Paper presented at the 35th Society for Behavioral Medicine Annual Conference, Philadelphia, Pennsylvania. |
| 14 | Alsallaq, R., Buttolph, J., Cleland, C.M., Hallet, T., Inwani, I., & Kurth, A. (2013). Estimating the impact of combined prevention interventions targeting 15-24 year-old men and women in Nyanza, Kenya. Presented at the 141st Annual Meeting and Exposition of the American Public Health Association, Boston, MA. |
| 15 | Buttolph, J., Inwani, I., Agot, K., Omanga, E., Walawanga, D., Cleland, C.M., & Kurth, A. (2013). Gender-specific awareness and acceptability of pre-exposure prophylaxis to prevent HIV infection among youth in Western Kenya: Implications for implementation. Presented at the 141st Annual Meeting and Exposition of the American Public Health Association, Boston, MA. |
| 16 | Buttolph, J., Inwani, I., Agot, K., Omanga, E., Walawanga, D., Cleland, C.M., & Kurth, A. (2013). Gender-specific awareness and acceptability of pre-exposure prophylaxis to prevent HIV infection among youth in Western Kenya: Implications for implementation. Presented at the 8th International Conference on HIV Treatment and Prevention Adherence. |
| 17 | Kurth, A., Inwani, I., Agot, K., Cleland, C.M., Alsallaq, R., & Buttolph, J. (2013). Combination HIV prevention for youth in high-burden settings: MP3 Youth. Presented at the 8th International Conference on HIV Treatment and Prevention Adherence. |
| 18 | Sivapalasingham, S., Ahmed, A., McClelland, R.S., Cleland, C.M., Fajans, M., Anderson, M.E., Masese, L., Mwamzaka, M., Shafi, J., Marshed, F., Laverty, M., Jaoko, W., & Kurth, A. (2012). An effective behavioral intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women. Presented at the XIX International AIDS Conference, Washington, DC. |
| 19 | Simon, V., Cleland, C.M., & Feiring, C. (2012). Longitudinal Associations between Youths’ Reactions to Childhood Sexual Abuse and Subsequent Strategies for Processing Abuse Experiences. Presented at the Biennial Meeting of the Society for Research on Adolescence, Vancouver, British Columbia, Canada. |
| 20 | Magura, S. & Cleland, C.M. (2011). Structural equation modeling with cross-lagged paths to evaluate Alcoholics Anonymous’ effect on drinking. Presented at the Annual Meeting of the American Evaluation Association, Anaheim, California. |
| 21 | Linick, J.L., Leonard, N., Cleland, C.M., Tottenham, N., Massey, Z., & Gwadz, M.V. (2011). Callous-Unemotional Traits, Fear Recognition, and Emotion Regulation in Incarcerated Youth. Presented at the Biennial Meeting of the Society for Research in Child Development, Montreal, Quebec, Canada. |
| 22 | Friedman, S.R., Pouget, E.R., Tempalski, B., Cleland, C.M., Chatterjee, S., & Cooper, H.L.F. (2011). Social drivers of drug-related harms among IDUs: Research to assist harm reduction agencies to plan political and policy long-term agendas. Presented at the Annual Meeting of the International Harm Reduction Association, Beruit, Lebanon. |
| 23 | Tempalski, B., Cleland, C.M., Pouget, E.R., Chatterjee, S., & Friedman, S.R. (2010). Persistence of low drug treatment coverage for injection drug users in large US metropolitan areas. Presented at the 8th National Harm Reduction Conference, Austin, Texas. |
| 24 | Gwadz, M.V., Leonard, N., Banfield, A., Colon, P., Bowens, D., Riedel, M., Ritchie, A., Cleland, C.M., & Mildvan, D. (2010). Peer-driven intervention to minimize racial/ethnic disparities in HIV/AIDS clinical trials. Presented at the Annual Meeting of the American Public Health Association, Denver, Colorado. |
| 25 | Rosenblum, A.B., Cleland, C.M., & Fong, C. (2010). Prescription opioid abuse predicts first admission into methadone maintenance treatment. Presented at the Annual Meeting of the American Association for the Treatment of Opioid Dependence (AATOD), Chicago, Illinois. |
| 26 | Friedman, S.R., Tempalski, B., Cooper, H.L.F., Cleland, C.M., Pouget, E.R., & Chatterjee, S. (2010). Comparative urban research: A promising epidemiologic and policy research tool. Presented at the NIDA International Forum, Scottsdale, Arizona. |
| 27 | Rosenblum, A.B., Cruciani, R., Portenoy, R.K., Dvorkin, E.D., Sundaram, A., & Cleland, C.M. (2010). Early results of a protocol to use buprenorphine for chronic pain in patients with aberrant drug-related behavior. Presented at the Annual Meeting of the College on Problems of Drug Dependence, Scottsdale, Arizona. |
| 28 | Gwadz, M.V., Leonard, N.L., Cleland, C.M., Colon, P., Banfield, A., Middelton, S., Constantini, G., Ritchie, A., Riedel, M., Bowens, D., Quiles, R., Tharaken, M., Aguirre, M., Mildvan, D., & The ACT2 Project Collaborative Research Team (2010). Peer-Driven Intervention Increases Rates of Screening for AIDS Clinical Trials among Persons Living with HIV/AIDS from Racial/Ethnic Minority Backgrounds. Presented at the XVIII International AIDS Conference, Vienna, Austria. |
| 29 | Cleland, C.M., Rosenblum, A., Fong, C., Parrino, M., & Magura, S. (2010). Prescription opioid abuse predicts first admission into methadone maintenance treatment. Presented at the Annual Meeting of the College on Problems of Drug Dependence, Scottsdale, Arizona. |
| 30 | Sacks, S., Cleland, C.M., McKendrick, K. (2009). Modified TC for persons with co-occurring disorders: A meta-analysis. Presented at the Annual Meeting of the College on Problems of Drug Dependence, Reno, Nevada. |
| 31 | Cleland, C.M., Rosenblum, A., Fong, C., Parrino, M., & Magura, S. (2009). Age effects on heroin and prescription opioid abuse among enrollees into methadone maintenance treatment. Presented at the Annual Meeting of the College on Problems of Drug Dependence, Reno, Nevada. |
| 32 | Tempalski, B., Lieb, S., Cleland, C.M., Cooper, H., & Friedman, S. (2009). Geographic patterns of change in IDU-related HIV prevalence rates across 96 metropolitan statistical areas, 1992-2002. Presented at the Annual Meeting of the Association of American Geographers, Las Vegas, Nevada. |
| 33 | Neaigus, A., Friedman, S., Gyarmathy, V.A., Cleland, C.M., & Des Jarlais, D.C. (2008). Heroin injectors who also use non-injection heroin have lower injecting frequency and lower HCV infection rates. Presented at the 19th Annual International Harm Reduction Association Conference, Barcelona, Spain. |
| 34 | Fiering, C. & Cleland, C.M. (2008). Stigmatization as a pathway to disrupted self-development in sexually abused youth. Paper Presented at the Biennial Meeting of the Society for Research on Adolescence, Chicago, IL. |
| 35 | Cleland, C.M., Des Jarlais, D.C., Perlis, T.E., Stimson, G., Poznyak, V., and the WHO Phase II Drug Injection Collaborative Study Group (2007). HIV risk behaviors among female IDUs in developing and transitional countries. Poster Presented at the Annual Meeting of the College on Problems of Drug Dependence, Québec City, Canada. |
| 36 | Fiering, C., Miller-Johnson, S., & Cleland, C.M. (2007). Stigmatization as a pathway to delinquency in sexually abused youth. Paper Presented at the Biennial Meeting of the Society for Research in Child Development, Boston, MA. |
| 37 | Gwadz, M., & Cleland, C.M. (2006). Project ACT: A pilot intervention to increase screening for AIDS clinical trials among racial/ethnic minorities and women in New York City. Poster presented at the International AIDS Conference, Toronto, Canada. |
| 38 | Cleland, C.M., Deren, S., Fuller, C.M., Blaney, S., McMahon, J.M., Tortu, S., Des Jarlais, D.C., & Vlahov, D. (2005). Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Paper presented at the Annual Meeting of the American Public Health Association, Philadelphia, PA. |
| 39 | Cleland, C.M., Gwadz, M., Leonard, N., Rotko, L., & Gostnell, K. (2004). Multilevel modeling of family data in HIV research. Paper presented at the Annual NIMH International Research Conference on the Role of Families in Preventing and Adapting to HIV/AIDS, Atlanta, GA. |
| 40 | Cleland, C.M., Fong, C., Foote, J., Magura, S., & Rosenblum, A. (2003). Multiple imputation and listwise deletion approaches to missing data in a clinical trial. Poster Presented at the Annual Meeting of the College on Problems of Drug Dependence, Bal Harbour, FL. |
| 41 | Cleland, C.M. & Lewis, M. (2001). Differences in resistance to temptation and deception between Japanese and American preschoolers. Poster Presented at the Biennial Meeting of the Society for Research in Child Development, Minneapolis, MN. |
| 42 | Cleland, C.M., & Lewis, M. (1999). More evidence of deception in young children. Poster Presented at the Biennial Meeting of the Society for Research in Child Development, Albuquerque, NM. |
| 43 | Lipton, D. S., Pearson, F. S., Cleland, C.M., & Yee, D. (1998). Synthesizing correctional treatment outcomes: Preliminary findings from CDATE. Paper presented at the Office of Justice Programs/Corrections Program Office National Workshop on Assessing the Effectiveness of Corrections Programs, Chicago, IL. |
| 44 | Pearson, F. S., Lipton, D. S., Cleland, C.M., & Yee, D. (1998). A review and meta-analysis of the effects of experiential challenge programs on recidivism. Paper Presented at the Annual Meeting of the American Society of Criminology. |
| 45 | Cleland, C.M., Yee, D., Pearson, F. S., & Lipton, D. S. (1997). Does age make a difference? A meta-analytic approach to reductions in criminal offending for juveniles and adults. Paper Presented at the Annual Meeting of the American Society of Criminology, San Diego, CA. |
| 46 | Pearson, F. S., Lipton, D. S., & Cleland, C.M. (1997). Rehabilitative programs in adult corrections: CDATE meta-analyses. Paper Presented at the Annual Meeting of the American Society of Criminology, San Diego, CA. |
| 47 | Cleland, C.M., Pearson, F. S., & Lipton, D. S. (1996). A meta-analytic approach to the link between needs-targeted treatment and reductions in criminal offending. Paper Presented at the Annual Meeting of the American Society of Criminology, Chicago, IL. |
| 48 | Pearson, F. S., Lipton, D. S., & Cleland, C.M. (1996). Some preliminary findings from the CDATE Project. Paper Presented at the Annual Meeting of the American Society of Criminology, Chicago, IL. |
| 49 | Pearson, F. S., Lipton, D. S., Cleland, C.M., & O’Kane, J. B. (1995). Meta-analysis on the effectiveness of correctional treatment: Another approach and extension of the time frame to 1994 - A progress report. Paper Presented at the Annual Meeting of the American Society of Criminology, Boston, MA. |
| 1 | Building an Efficient Multicomponent Intervention to Improve Engagement along the HIV Care Continuum. NYU Langone, Department of Population Health. October 28, 2020. |
| 2 | What is happening with my research project right now? Tools for building and sharing dynamic reports from web-based data collection. NYU Langone, Department of Population Health. September 26, 2018. |
| 3 | Developing a quantitative analysis plan for early phase research. Center for Drug Use and HIV Research. April 18, 2018. |
| 4 | Factor Analysis. Guest Lecture for Maria Khan, Department of Population Health, NYU School of Medicine. April 12, 2018. |
| 5 | What is happening with my research project right now? Tools for building and sharing dynamic reports from web-based data collection. NYU Meyers College of Nursing. March 27, 2018. |
| 6 | Underused research designs: MOST and SMART. Guest Lecture for Danielle Ompad, NYU College of Global Public Health. December 6, 2017. |
| 7 | An introduction to REDCap for data collection and research project management. NYU Meyers College of Nursing. November 30, 2017. |
| 8 | R Hands-On Practice. NYU Meyers College of Nursing. October 26, 2017. |
| 9 | Introduction to R: Get Started and See the Possibilities. NYU Meyers College of Nursing. October 27, 2016. |
| 10 | Introduction to R: Get Started and See the Possibilities. NYU Meyers College of Nursing. April 26, 2016. |
| 11 | Multilevel Modeling of Cross-Sectional Data: Introduction with Examples. NYU College of Nursing. April 18, 2013. |
| 12 | Multilevel Modeling of Cross-Sectional Data: Introduction with Examples. NYU College of Nursing. May 19, 2011. |
| 13 | Power Analysis for Proposals: Concepts and Methods. NDRI Statistical Support Group. January 20, 2009. |
| 14 | Power Analysis for Proposals: Concepts and Methods. NDRI Statistical Support Group. October 28, 2008. |
| 15 | Multilevel Modeling of Cross-Sectional Data: Introduction with Examples. NDRI Statistical Support Group. June 10, 2008. |
| 16 | Respondent-Driven Sampling II: Illustrations, Limitations, and Discussion. NDRI Statistical Support Group. February 14, 2008. |
| 17 | Statistical Analysis of Respondent-Driven Samples. NDRI Statistical Support Group. June 26, 2007. |
| 18 | An Introduction to Factor Analysis. NDRI Behavioral Science Training Pre- and Post-Doctoral Group. March 7, 2005. |
| 19 | An Introduction to Structural Equation Modeling. NDRI Statistical Support Group. April 15, 2004. |
| 20 | Using Graphics Effectively in Data Analysis. NDRI Statistical Support Group. February 11, 2003. |
| 21 | SPSS Training. NDRI Statistical Support Group. February 4, 2003. |
| 22 | Model Selection. NDRI Statistical Support Group. September 10, 2002. |
| 23 | Generalized Estimating Equations (GEE) in R. NDRI Statistical Support Group. May 7, 2002. |
| Title | Number | PI | Start | End | Funder | Details | Role |
|---|---|---|---|---|---|---|---|
| Validation of a pragmatic implementation measure for task sharing in mental health services | R01MH122851 | Yang | 2020-05-01 | 2024-02-28 | NIMH | The goal of this proposal is to validate a measure intended to help program implementers identify the barriers and facilitators so that they can improve mental health interventions that employ nonspecialists, such as lay health workers, to provide evidence-based mental health care. We seek to demonstrate that the tool can facilitate rapid improvements in service quality, and ultimately help alleviate the global public health issue of the severe shortage of mental health specialists in many low-resource settings, including in rural areas in the U.S. | Co-Investigator & Biostatistician |
| Implementing tobacco use treatment in HIV clinics in Viet Nam | R01CA240481 | Shelley | 2020-05-01 | 2025-04-30 | NCI | The specific aims are to: 1) Adapt and tailor the Intervention to PLWH and HIV care settings, 2) Conduct a 3-arm RCT comparing the cost effectiveness of three models of care based on biochemically validated 6-month Smoking Abstinence; and 3) Evaluate multilevel factors that facilitate or impede implementation and potential for sustainability of TUT in HIV treatment settings in Viet Nam. | Co-Investigator & Biostatistician |
| Measure development to accelerate the translation of evidence based clinical guidelines into practice | U01TR002008 | Shelley / Berry | 2017-08-07 | 2021-06-30 | NCATS | Half of the U.S. adult population has one or more preventable risk factors for cardiovascular disease (CVD) including hypertension (HTN) and hyperlipidemia, but only 10% are meeting all of their clinical goals due to suboptimal adoption of guideline recommended care in primary care practices. We will study elements of care structure and processes (e.g., decision support, care coordination) that are hypothesized to be associated with improvements in CVD-related patient outcomes. We will then develop and validate a measurement tool for identifying gaps in care structures and processes that are amenable to change, and if implemented by primary care practices, will improve CVD-related health. | Biostatistician |
| Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease | R18HS023922 | Shelley | 2017-05-01 | 2018-04-30 | AHRQ | The purpose of the study is to fill the research-to-practice gap in primary care by testing the effectiveness of practice facilitation as a quality improvement strategy for implementing evidence-based guidelines for reducing risk factors related to heart disease in small primary care practices in New York City. (Note: Now in one-year no-cost extension from April 2018 end date) | Biostatistician |
| Using MOST to Optimize an HIV Care Continuum Intervention for Vulnerable Populations (HTH2-MOST) | R01DA040480 | Gwadz / Collins | 2016-09-01 | 2020-08-31 | NIDA | The present study targets the large population of persons living with HIV/AIDS (PLHA) in the U.S. who are both insufficiently engaged in HIV primary care and not taking antiretroviral therapy (ART), who are mainly African American/Black and Latino. NIH has emphasized the urgent need for new research approaches to advance intervention science, and the proposed project employs a new, potent, and innovative research methodology, the Multiphase Optimization STrategy (MOST), a framework for developing highly efficacious, efficient, scalable, and cost-effective interventions. The proposed study has the highest public health significance: it addresses a vulnerable population of PLHA, including the critically important subpopulations of men who have sex with men (MSM) and substance users; will develop an efficient and cost effective intervention to increase engagement along the HIV care continuum for these vulnerable groups; and addresses two areas highlighted in the August 2015 notice on research priorities from the NIH Office of AIDS Research (NOT-OD-15-137), namely, engaging PLHA in prevention/treatment services, and reducing HIV/AIDS-related racial/ethnic disparities.Role: Co-Investigator & Statistician | Biostatistician |
| Adherence Connection for Counseling, Education, and Support (ACCESS): A Proof of Concept Study | K23NR015970-01 | Navarra | 2015-09-01 | 2018-08-31 | NINR | The goals of this proposal are to: 1) conduct a novel research project under the mentorship of an interdisciplinary team of expert researchers; 2) acquire expertise in development, implementation and evaluation of technology supported behavioral interventions, health disparities, and advanced qualitative and mixed methods design and analysis through firsthand experience, didactic interactions with mentors, and graduate level coursework; 3) build a network of colleagues and collaborators within New York University and elsewhere through this research and participation at national and international meetings; and 4) prepare and submit a federal research grant, based upon the skills and findings from this award period. | Co-Investigator & Biostatistician |
| High-yield HIV testing, facilitated linkage to care, and prevention for female youth in Kenya | R01AI122797 | Kurth / Inwani / Agot | 2015-08-01 | 2020-07-31 | NIAID | We propose an implementation science framework to address the HIV prevention and treatment continuum that will inform best practices in identifying high-need young women, providing testing options, and primary HIV prevention as well as linkage to HIV care, in SSA. | Biostatistician |
| Implementing tobacco use treatment guidelines in public health clinics in Vietnam | R01CA175329 | Shelley | 2013-10-01 | 2018-09-30 | NCI | The objective of this proposal is to fill the current research-to-practice gap by conducting a randomized controlled trial that compares the effectiveness and cost effectiveness of two practical and highly replicable strategies for implementing evidence-based guidelines for the treatment of tobacco use in public health clinics in Vietnam. | Biostatistician |
| An Interdisciplinary Approach to HIV and Other Infectious Diseases of Drug Use | P30DA011041 | Deren / Hagan | 1998-04-01 | 2023-01-31 | NIDA | The Center for Drug Use and HIV Research (CDUHR) emphasizes socio-behavioral factors influencing HIV prevention and transmission and has made important contributions to the field. This renewal expands our scope of research to a wider perspective on clinical infectious diseases (e.g., sexually transmitted infections [STIs] and Hepatitis C [HCV]) in drug users and their communities and strengthens our interdisciplinary focus by integrating clinical infectious diseases with socio-behavioral-epidemiologic research. | Methods Core Co-Director |
| Title | Number | PI | Start | End | Funder | Details | Role |
|---|---|---|---|---|---|---|---|
| Extending Sleep to Reverse Metabolic Syndrome in Middle-Aged Adults: Acceptability and Feasibility of a Sleep Intervention | UL1TR001445 | Malone | 2018-04-01 | 2019-03-31 | NYU-HHC CTSI | We will establish the feasibility and acceptability of a 12-week self-management for adequate sleep intervention (SASI) in community-dwelling, racially/ethnically diverse, short-sleeping, middle-aged adults with MetS. We will also explore the efficacy of SASI on sleep duration, individual MetS factors, MetS risk behaviors, sleep deprivation symptoms associated with MetS risk behaviors, and self-regulation. Additionally, we will explore barriers and facilitators to extending sleep using qualitative interviews. | Advisor |
| Feasibility and acceptability of a text message intervention in Vietnam | R21CA225852 | Shelley/Nguyen | 2017-08-15 | 2019-08-14 | NCI | The objective of this study is to develop and test the feasibility and acceptability of a smoking cessation SMS intervention adapted to the sociocultural context, language and communication styles of Vietnamese smokers. | Biostatistician |
| Leveraging Technology to Address Unhealthy Drug use in primary care settings | R34DA040830 | McNeely | 2017-07-01 | 2019-06-30 | NIDA | The proposed study aims to develop and test a new model of integrating substance use screening and brief interventions in primary care settings. The Substance Use Screening and Intervention Tool (SUSIT) utilizes health information technology to assist primary care providers in addressing unhealthy drug use by providing patient self-administered screening, clinical decision support, and clinical reminders. | Biostatistician |
| Accuracy of Oral HIV Self-tests in Kenya | NA | Kurth | 2013-07-01 | 2014-02-28 | 3ie | Our objective was to evaluate the performance and accuracy parameters of oral fluid HIV self-testing in the general population of Kenya. The study aims were to determine (1) the ability of participants with unknown HIV status to correctly perform and interpret a rapid oral fluid (OF) HIV test and to determine accuracy of HST results compared to staff/lab testing (i.e., sensitivity and specificity measures of validation), and (2) participant attitudes towards OF self-testing (i.e., OF HST acceptability and feasibility). | Biostatistician |
| Advancing Research on Youth Settings by Exploring Program Quality and Outcomes for Runaway/Homeless Youth | 182738 | Gwadz | 2013-01-01 | 2015-12-31 | William T Grant | Runaway/homeless youth (RHY) are highly vulnerable, experiencing high rates of trauma, and serious behavioral and health problems. A diverse network of settings has developed to treat RHY. Yet almost no research has been conducted on RHY settings, and thus we do not understand how the settings (a) work, (b) affect youth development, or (c) can be improved. | Biostatistician |
| Improving adherence to smoking cessation medication to enhance cessation outcomes among HIV+ patients | R34DA031636 | Shelley | 2012-05-01 | 2014-04-30 | NIDA | The primary aims are: 1) to determine the feasibility and acceptability of conducting a telephone delivered cessation counseling and text message intervention among a HIV+ clinic-based population, 2) to estimate and compare the effect of three models of smoking cessation treatment on adherence to varenicline and smoking abstinence at end of treatment (12 weeks) and 24-week follow-up. | Biostatistician |
| Correlates and Consequences of Increased Immune Activation in HIV(+) and (-) IDUs | R01DA033777 | Markowitz | 2012-04-01 | 2017-03-31 | NIDA | The aim of this project is to use a systems biology approach to understand the mechanisms, correlates, and consequences of increased immune activation observed systemically and in GI-associated lymphoid tissue in HIV-1 infected and uninfected IDUs. | Biostatistician |
| Validation of a Short Drug Screen in Primary Care | NA | McNeely | 2012-01-01 | 2012-12-31 | NYU-HHC CTSI | Comprehensive substance use screening is recommended in primary care, but most practices have no clinical procedures for identifying the use of substances other than tobacco. An optimal substance use screening tool would include tobacco, alcohol, illicit drugs, and misuse of prescription drugs; be easy to use and to remember; and be precise enough to streamline the subsequent assessment for substance use disorders in those who screen positive. It should have sufficient sensitivity and specificity to accurately detect past year substance use. We have developed and now propose a study to validate a ‘Short Drug Screen (SDS)’ that fits these requirements, and could be more easily integrated into primary care settings. | Biostatistician |
| Integrating Behavioral Skills with a Mobile Biosensor for At-Risk Teen Mothers | R34DA032960 | Leonard / Gwadz | 2012-01-01 | 2014-12-31 | NIDA | This proposal seeks to examine the efficacy of a bio-psychosocial intervention for at-risk adolescent mothers that builds skills in effective parenting, regulating emotions, avoiding risk behaviors, and building supportive relationships. | Biostatistician |
| Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV | R01DA032083 | Gwadz | 2011-07-25 | 2016-04-30 | NIDA | The primary goal of the study is to evaluate the efficacy of a multi-level enhanced peer-driven intervention PDI) to seek and test heterosexuals at high risk for HIV (HHR), and treat and retain them into care if they are found to be HIV infected. The PDI is tailored specifically for HHR and includes computerized, navigation, and peer delivered components to enhance the intervention’s future uptake and sustainability. The study builds on the CDC’s National HIV Behavioral Surveillance (NHBS) studies. | Biostatistician |
| Testing and Linkage to Care for Injecting Drug Users in Kenya: TLC-IDU Kenya | R01DA032080 | Kurth | 2011-07-25 | 2016-04-30 | NIDA | An increasing number of HIV infections in sub-Saharan Africa are occurring among injecting drug users (IDUs), a most-at-risk population (MARP). Evidence-based HIV prevention and care services for IDUs such as needle and syringe exchange programs (NSPs), opioid substitution therapy (OST), and antiretroviral therapy (ART) adherence support specific to HIV+ IDUs have been almost non-existent in this region. The Government of Kenya is currently conducting size estimations of IDUs and is preparing to launch a first-ever NSP. Our team of policy leaders, addiction, biobehavioral and health services scientists will utilize the NSP platform to seek out IDUs, deliver HIV testing, determine CD4 count and link to ART, and to evaluate community viral load impact. | Biostatistician |
| Intervention to Increase Timely Initiation of HAART Among Those Who Delay/Decline | R34MH093352 | Gwadz | 2011-07-25 | 2014-04-30 | NIMH | Many persons living with HIV/AIDS (PLHA) in the U.S. (an estimated 10-19% of PLHA), predominantly people of color, delay taking Highly Active Antiretroviral Therapy (HAART) until late in their HIV disease or never initiate HAART when it is medically necessary, even when engaged in care. They experience disproportionately higher morbidity and earlier mortality compared to their peers on HAART, and higher health care costs. Further, they are less likely to achieve virologic suppression, increasing the probability of HIV transmission to others. This study seeks to create a culturally-targeted, sustainable, multi-level, and individualized video-based behavioral intervention for the population of PLHA who are medically eligible for HAART but who have delayed or declined HAART. | Biostatistician |
| Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings | R01AI094607 | Kurth | 2011-04-01 | 2015-03-31 | NIDA | Our team of biobehavioral and clinical scientists, mathematical modelers, and trial design specialists will: Identify gender(sex)-specific drivers of HIV acquisition risk, including pregnancy among females, for youth in sub-Saharan Africa, and interventions to best address those risks. Conduct mathematical modeling to select optimal combination intervention package components and to assess potential population-level impact. In partnership with a highly-productive nongovernmental organization (NGO) that is delivering PEPFAR-funded HIV prevention services, develop and pilot a combination HIV prevention package specific for female and for male youth – ‘MP3-Youth’ – in Migori County, Nyanza Province, Kenya. | Biostatistician |
| Comparative Effectiveness of Web-based vs. Traditional Adolescent HIV Prevention | RC1DA028415 | Marsch | 2009-09-30 | 2011-08-31 | NIDA | We previously developed an interactive, customizable, web-based program focused on the prevention of HIV, STIs and hepatitis for youth that incorporates effective components of both prevention science and educational technologies that promote mastery of key skills and information. In the presently proposed trial, we will examine the comparative effectiveness and cost-effectiveness of the web-based HIV, hepatitis and STI prevention intervention when offered to youth in outpatient, community-based substance abuse treatment when directly compared to a traditional (educator-delivered) HIV and infectious disease prevention intervention. | Biostatistician |
| Computerized Psychosocial Treatment for Offenders with Substance Use Disorders | RC2DA028967 | Sacks | 2009-09-30 | 2011-08-31 | NIDA | This project is significant in its use of an innovative computer-based technology (of demonstrated efficacy with a related population of substance users) to produce a dramatic increase in the effective and cost-effective delivery of psychosocial treatment for male and female substance-abusing offenders. This 2-year research project has the potential to accelerate research and dissemination efforts to enable widespread reach of science-based psychosocial treatment to individuals in criminal justice settings across the U.S. | Biostatistician |
| Longitudinal Study of Substance Use, Incarceration, and STI is the US | R03DA026735 | Khan | 2009-08-01 | 2011-03-31 | NIDA | This study aims to: (1) measure longitudinal associations between adolescent substance use and multiple sexual partnerships and STI in adulthood and evaluate whether race or criminal justice involvement moderates the relationships; (2) measure associations between incarceration and multiple sexual partnerships and STI in adulthood; and (3) evaluate the degree to which incarceration in adulthood mediates the relationships between adolescent substance use and multiple sexual partnerships and STI in adulthood. | Biostatistician |
| Prevalence of Prescription Opioid Abuse among New Admission to OTPs | NA | Rosenblum | 2009-01-01 | 2010-12-31 | AATOD | In collaboration with the American Association for the Treatment of Opioid Dependence (AATOD), NDRI is conducting a survey of opioid abuse among methadone enrollees. The objective of the survey is to determine the prevalence and type of prescription opioid abuse among admissions to methadone programs and to describe the relationship between type of opioid drug and pain severity, psychological distress and dependence severity. | Biostatistician |
| Prevention Intervention for Drug Use & Related Behaviors with Incarcerated Youth | R01DA024764 | Leonard | 2008-09-15 | 2012-06-30 | NIDA | Power Source is a promising prevention intervention developed by providers who work with offending youth. The aims of this study are to: (1) examine the effects of the Power Source intervention with incarcerated youth on internalizing and externalizing behavior problems, recidivism, delinquent behavior, and substance use; (2) examine the efficacy of the intervention on its most proximal targets (emotional regulation strategies and social cognitive skills) and determine whether these mediate the effects of the intervention on behavioral outcomes; (3) explore moderators of the Power Source intervention’s efficacy; and (4) explore the effects of the intervention on HIV-related sexual and substance use risk behaviors. | Biostatistician |
| Recent Changes in HIV Testing Recommendations: Impact on Youth at Risk | 106872-42-RGAT | Gwadz | 2007-07-31 | 06/31/2008 | amfAR | This was a multi-method and multi-level study involving quantitative and qualitative methods. To better understand how to increase the public health impact of HIV testing among homeless youth (HY), the specific aims of this study were to: (1) describe rates of and circumstances surrounding HY testing from the perspectives of HY (number, type, and dates of HIV tests; how initiated; locations, experiences, serostatus outcomes; and subsequent linkages to and use of health care or prevention); (2) examine influences at the individual, attitudinal, and social/structural levels that impede and facilitate HIV testing (rapid and conventional) and access to care from the perspectives of HY and their medical and non-medical service providers; and (3) explore two ethical issues: How HIV testing practices are associated with (a) pre- and post-test counseling; and (b) the use of health care post-test. | Biostatistician |
| Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials | R01AI070005 | Gwadz | 2007-05-01 | 2011-04-30 | NIAID | The specific aims of this study are to (1) examine the effects of the peer-driven intervention on rates of screening for and (secondarily) enrollment into ACTs; (2) examine whether the effects of the intervention on ACT screening and enrollment are mediated by changes in individual/ intrapersonal, attitudinal, and social/structural influences; (3) explore the positive and negative effects of ACT screening for those not found eligible for ACTs; and (4) describe the clinical characteristics of minority and female PLHA who are found ineligible for current ACTs, to address a long- term objective of developing new ACT practices that will result in higher eligibility rates for minority and female PLHA. | Biostatistician |
| Therapeutic Communities: A Three Country Comparison | R01DA018130 | Kressel | 2006-04-20 | 2010-03-31 | NIDA | The increasing prevalence of drug addiction and its public health consequences, particularly the spread of HIV/AIDS around the world, requires international collaborative research, training and technical assistance to improve our understanding of addiction, its prevention and treatment. This proposal will assemble an international network of scientists to foster research, training and the exchange of scientific information by working collaboratively on a study of therapeutic community treatment in three countries. | Biostatistician |
| HIV Knowledge and Risk Among Deaf Adolescents | R01DC007868 | Goldstein | 2005-04-01 | 2009-03-31 | NIDCD | The survey of HIV knowledge and risk behavior will be self-administered in American Sign Language on a laptop computer to 800 deaf adolescents who attend 11 high schools for the deaf. The results will fill an important gap in the literature regarding knowledge and risk behaviors among this at-risk group of adolescents.Role: Statistician | Biostatistician |
| Generalization of the Client Matching Protocol | R01DA015787 | DeLeon | 2005-02-15 | 2007-10-31 | NIDA | Tests the generalization of a standardized client-treatment matching interview and decision-tree algorithm (the Client Matching Protocol or CMP) through an 18-month secondary analysis study of TC-oriented agencies. This study has significant implications for both treatment and research in that it will provide empirical clarification of whether and how matching contributes to treatment improvement. | Biostatistician |
| Target Behavioral Care | NA | Cleland | 2003-09-12 | 2004-09-30 | SAMHSA/CSAT | The mission of the Target Behavioral Care (TBC) is to improve treatment in its target communities (South Bronx, Upper Manhattan, and Harlem) by building infrastructure that increases cooperation, coordination, and linkages among substance abuse treatment programs, health and mental health care providers, and other human services organizations. TBC focuses on reducing waiting time for treatment, reducing the treatment gap for underserved minorities, increasing treatment capacity, demonstrating effectiveness of treatment, and dissemination of treatment information. In collaboration with TBC as the NDRI evaluator, Dr. Cleland developed and refined outcome measures and analyzed project data. | Biostatistician |
| NDRI Colorado Research Center for CJDATS | U01DA016200 | Sacks, S. | 2002-09-25 | 2014-03-31 | NIDA | CJ-DATS2 calls for research on the process of diffusion (i.e., adopting, implementing and sustaining new treatment interventions), and on the efficacy of innovative implementation strategies. The goal of this proposal is to provide knowledge about the implementation of evidence-based drug abuse services in criminal justice settings. The investigators, an experienced and productive investigative team from CJDATS1, have been engaged in studies to improve the implementation of research-based practices and the overall quality of drug abuse treatment for two decades. The investigative team will use the TCU Program Change model as its conceptual framework since this model is specifically concerned with transferring research on substance abuse treatment into practice. | Biostatistician |
| “EXPANDED SYRINGE ACCESS PROGRAM”: Evaluation of the Impact of Syringe Deregulation in New York | R01DA12809 | Deren | 2001-04-01 | 2005-03-31 | NIDA | This project is led by Principal Investigator David Vlahov, PhD, of The New York Academy of Medicine.Few states in the U.S. have expanded their laws to increase access to sterile syringes. In New York, the opportunity to compare three modes of legal sterile syringe access (SEPs, pharmacies and health care providers) exists. The overall approach, using a historical control design, is to examine data before and after implementation of the New York State Expanded Syringe Access Program (ESAP). This involves coordination of data collection that includes phone surveys, ethnographic interviews, and street surveys of discarded needles. In addition, modifications are being made to currently funded interview studies of drug users about HIV and HCV risk to include information about sources, acquisition and disposal of syringes. The data are being examined using a “patterns of evidence” approach to consider generating inferences about the overall effects of the program. The NDRI component of the ESAP evaluation includes participating in the development of the evaluation design and collecting data from other ongoing projects recruiting IDUs to assess the impact of ESAP on sources of syringes and syringe sharing. | Evaluator |
| FAMILY FIRST: Interventions for HIV+ Mothers with Problem Drinking | R01AA012113 | Gwadz | 2000-09-22 | 2005-05-31 | NIAAA | The goal of this project is to design, implement, and evaluate the “Family First” program, an intervention for MLH with alcohol problems, many of whom also have drug use issues, who are raising adolescent children (aged 11-18 years). MLH are randomly assigned to either the “Family First” intervention, or a one-session brief video intervention. Based on the Social Action Model, the Family First intervention consists of individual sessions with the MLH over two phases (total 14 sessions) that target: a) reducing or eliminating problem drinking and drug use; b) improving the quality of parenting, and c) reducing sexual risk behavior. MLH are assessed at 3, 6, 12, 18, and 24 months following recruitment. The intervention is anticipated to improve parental monitoring, skills, and communication; therefore, the adolescent children of the MLH are also assessed at recruitment, 6 and 12 months. | Biostatistician |
| Group Motivational Intervention in Drug Abuse Treatment | R01DA12209 | Magura | 1999-12-20 | 2004-05-31 | NIDA | The specific aims of this study are: (1) to implement a new Group Motivational Intervention as an induction to standard outpatient treatment; (2) to conduct an efficacy trial of GMI, by contrasting drug-abusing patients voluntarily randomly assigned to two conditions: a) GMI followed by outpatient treatment “as usual”, and b) outpatient treatment “as usual”; (3) to determine in patient characteristics and treatment process variables which may predict drop-out and other differences in treatment outcomes; and (4) to conduct a cost-effectiveness analysis of GMI. | Biostatistician |
| Social Support & HIV Risk: Women Offenders in Recovery | R01DA11240 | Falkin | 1997-09-15 | 2003-07-31 | NIDA | The aims of the study are: to document longitudinally social support for women ex-offenders during the first seven months after leaving drug treatment; to assess ethnographically the function of various types of social support in relation to HIV risk reduction behaviors; to examine the interrelationships between various behavioral indicators of HIV/AIDS risk reduction and measures of HIV risk behaviors, social support, drug treatment and individual characteristics; to develop models to predict HIV-related risk reduction behaviors among women ex-offenders who have been mandated to drug treatment; and to synthesize research findings and recommend HIV intervention. | Biostatistician |
| Effectiveness of Self-Help for the Dually Diagnosed | R01DA11240 | Magura | 1997-08-15 | 2002-12-31 | NIDA | The goals of this project are: to examine the process by which persons dually diagnosed with substance abuse and mental illness initiate contact and become progressively involved in Double Trouble in Recovery (DTR); to develop an understanding of DTR group formation, development and dynamics; to measure and document the therapeutic mechanisms through which dual recovery groups are hypothesized to improve outcomes for their participants; to conduct an effectiveness study of DTR using longitudinal research; and to test a theory-driven model of the recovery process among dually diagnosed persons. | Biostatistician |